Objective. To examine the collaboration between physicians and pharmaceutical professionals in the provision of pharmacotherapy for patients with cardiovascular diseases, particularly arterial hypertension (AH). Materials and Methods. A comparative analysis of the structure and workflow of medical (MO) and pharmacy (PO) organizations in Kursk city and region was performed. The study included a survey of healthcare professionals involved in the medication provision process. Results. Significant discrepancies were identified between the prescribed and dispensed medications in four pharmacological groups, indicating insufficient coordination between physicians and pharmacy staff. Professional profiles of physicians and pharmacists were developed to characterize their roles in managing patients with AH. The study also highlighted the relevance of non-pharmacological approaches to disease management, including the improvement of patient compliance through counseling, identifying physical and psychological barriers to treatment, and preventive work with healthy individuals visiting pharmacies. Conclusion. The findings emphasize the need for close collaboration between physicians and pharmaceutical professionals, based on cross-communication and shared decision-making in the management of patients with arterial hypertension.
Inna M. Razdorskaya – Professor of the Department of Organization and Management of Pharmacy, Kursk State Medical University, Kursk, Russia.
Galina S. Mal – Professor, Head of the Department of Pharmacology, Kursk State Medical University, Kursk, Russia.
1. Ministry of Health of the Russian Federation. Order dated August 31, 2016 No. 647n On approval of the rules of good pharmacy practice of medicinal products for medical use. Available at: https://normativ.kontur.ru/document?moduleId=1&documentId=286918. Accessed: 20 Aug 2025. (In Russ).
2. Pharmaceutical practice development: patient-centered approach. Basel: City Hope International Inc; 2008. Available at: https://www.fip.org/file/1722. Accessed: 20 Aug 2025. (In Russ).
3. Morgado MP, Morgado SR, Mendes LC, et al. Pharmacist interventions to enhance blood pressure control and adherence to antihypertensive therapy: review and meta-analysis. Am J Health Syst Pharm. 2011;68(3):241–253. DOI: 10.2146/ajhp090656
4. Santschi V, Chiolero A, Colosimo AL, et al. Improving blood pressure control through pharmacist interventions: meta-analysis of randomized controlled trials. J Am Heart Assoc. 2014;3(2). DOI: 10.1161/JAHA.113.000718
5. Weber CA, Ernst MF, Sezate GS, et al. Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures. Arch Intern Med. 2010;170(18):1634–9. DOI: 10.1001/archinternmed.2010.349
6. Chisholm-Burns MA, KimLee J, Spivey CA, et al. US pharmacists effect as team members on patient care: systematic review and meta-analyses. Med Care. 2010;48(10):923–33. DOI: 10.1097/MLR.0b013e3181e57962
7. Crilly P, Kayyali R. Role of community pharmacists in hypertension management. Clin Pharm. 2017;9(10):1–2. DOI: 10.1211/CP.2017.20203671
8. Omboni S, Sala E. The pharmacist and the management of arterial hypertension: the role of blood pressure monitoring and telemonitoring. Expert Rev Cardiovasc Ther. 2015;13(2):209–21. DOI: 10.1586/14779072.2015.1001368
9. Strategy for chronic disease prevention in Europe: a vision from the CINDI framework. Copenhagen: WHO. 2005; 64. Available at: https://iris.who.int/bitstream/handle/10665/107570/E83057R.pdf?sequence=2. Accessed: 20 Aug 2025. (In Russ).
10. Lagutkina TP, Loskutova EE, Dorofeeva VV, Kosova IV. Pharmaceutical counseling as a tool to implement the health literacy concept. Mediko-farmatsevticheskiy zhurnal Puls. 2020;22(1):62–9. (In Russ).
11. Townsend N, Wilson L, Bhatnagar P, et al. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J. 2016;37(42):3232–45. DOI: 10.1093/eurheartj/ehw334
12. Astanina SY, Kalinina AM, Shepel RN, Drapkina OM. Methodological aspects of communicative competence development in general practitioners during preventive counseling. Kardiovaskulyarnaya terapiya i profilaktika. 2023;22(2S):36–48. (In Russ). DOI: 10.15829/1728-8800-2023-3648
13. Solozhenkina LI, Butina AP. Marketing study of the assortment and sales of drugs affecting the renin-angiotensin system. Blagoveshchensk; 2018. Available at: https://www.google.com/url?sa=t&source=web&rct=j&opi=89978449&url=https://www.informio.ru/files/main/documents/2018/12/Butina.docx&ved=2ahUKEwi56rCojq-PAxV_s1YBHfIYHoYQFnoECBgQAQ&usg=AOvVaw1t0aF_8t1PbZ7N7fbt6bra. Accessed: 20 Aug 2025. (In Russ).
14. Gromova IP, Korolevskaya OS. Marketing analysis of beta-blockers used in hypertension therapy. In: Current issues in modern medical science and healthcare. Proc V Int (75th All-Russian) Sci-Pract Conf. Yekaterinburg: Ural State Medical University; 2020:473–6. Available at: https://elib.usma.ru/bitstream/usma/3452/1/USMU_Sbornik_statei_2020_3_113.pdf. Accessed: 20 Aug 2025. (In Russ).
15. Carrington M. Prehypertension causes a mounting problem of harmful cardiovascular disease in young adults. J Hypertens. 2009;27(2):214–5. DOI: 10.1097/HJH.0b013e328325d1a0
16. Ibn-Sina. Selected works. Tashkent: Publishing House of the Central Committee of the Communist Party of Uzbekistan; 1981:120. (In Russ).
17. Zhuo L, Ji S, et al. Incidence and risk factors of progression from prehypertension or hypertension to diabetes among older adults of Northeastern China: a prospective cohort study. Biomed Environ Sci. 2022;35(12):1150–5.
18. Sendra-Lillo J, Sabater-Hernandez D, Sendra-Ortola A, Martinez-Martinez F. Agreement between community pharmacy, physician’s office and home blood pressure measurement methods: the Palmera study. Am J Hypertens. 2012;25(3):290–6. DOI: 10.1038/ajh.2011.207
19. Kazaryan OV, Mishina EY, Soboleva OS, Umanskaya MB. Symbolism of the white coat in the medical profession. Probl Sotsialnoi Gig Zdravookhr Istor Med. 2023;31(Suppl 1):725–7. DOI: 10.32687/0869-866X-2023-31-s1-725-727
20. Sendra-Lillo J, Sabater-Hernandez D, Sendra-Ortola A, Martinez-Martinez F. Comparison of the white-coat effect in community pharmacy versus the physician’s office: the Palmera study. Blood Press Monit. 2011;16(2):62–6. DOI: 10.1097/MBP.0b013e328344c755
The article can be purchased
electronic!
PDF format
700 руб
DOI: 10.14489/lcmp.2025.03.pp.004-014
Article type:
Research Article
Make a request
